We are a specialty pharmaceutical company engaged in research, development and
manufacture of innovative Aversion® Technology and related product candidates.
Product candidates developed with Aversion® Technology and containing opioid
analgesic active ingredients are intended to effectively treat pain and also
discourage the most common methods of pharmaceutical product misuse and abuse
including; (i) intravenous injection of dissolved tablets or capsules, (ii)
nasal snorting of crushed tablets or capsules and (iii) intentional swallowing
of excessive numbers of tablets or capsules. Acurox™ Tablets, our lead product
candidate utilizing Aversion® Technology, is being developed pursuant to an
active investigational new drug application (“IND”) on file with the U.S. Food
and Drug Administration (“FDA”).  ...